EMEA-002469-PIP01-18
Key facts
| Active substance |
Pyrimidinyl-aminopyridine dual leucine zipper kinase inhibitor (GDC-0134)
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0099/2019
|
| PIP number |
EMEA-002469-PIP01-18
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of amyotrophic lateral sclerosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Roche Registration GmbH
Tel. +41 6168 79411 |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|